Moderna shares outstanding MRNA
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 398M
- On a year earlier
- +2.6%
- more shares
Moderna had 398M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 392M | +1% |
| FY2024 | 387M | +1% |
| FY2023 | 382M | −6% |
| FY2022 | 407M | −6% |
| FY2021 | 431M | +9% |
| FY2020 | 396.7M | +19% |
| FY2019 | 334.4M | +165% |
| FY2018 | 126.3M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 398M | +3% | |
| Q1 FY26 | 395M | +2% | |
| Q4 FY25 | 392M | +1% | |
| Q3 FY25 | 390M | −2% | |
| Q2 FY25 | 388M | +1% | |
| Q1 FY25 | 386M | +1% | |
| Q4 FY24 | 387M | +1% | |
| Q3 FY24 | 399M | +5% | |
| Q2 FY24 | 384M | +1% | |
| Q1 FY24 | 382M | −6% | |
| Q4 FY23 | 382M | −6% | |
| Q3 FY23 | 381M | −8% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Moderna
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.